Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
HealthXCapital is an early-stage venture capital firm based in Singapore, founded to tackle healthcare challenges in the Asia-Pacific region. The firm is backed by Jungle Ventures and Apollo Hospitals, focusing on enhancing access and affordability in healthcare. It invests in innovative startups with a particular emphasis on Southeast Asia and India.
HealthXCapital invests in early-stage healthcare startups, particularly those addressing non-communicable diseases and lifestyle-related health issues in the APAC region. The firm targets sectors such as point-of-care diagnostics, home health solutions, preventive health solutions, digital health, biomarkers, and artificial intelligence/machine learning. Typical investment stages include pre-seed, seed, and seed+ (extension).
Notable portfolio companies include Breath Diagnostics, developing a lung cancer detection solution; Child Health Imprints, improving neonatal care with IoT and AI; Homage, providing on-demand caregiving services; Jana Care, offering point-of-care diagnostics; Medfin, enhancing surgical experiences; Praktice.ai, optimizing healthcare staffing; Stanplus, India's largest emergency response platform; and THB, developing clinical data platforms.
Email info@healthxcapital.com with your deck to pitch HealthXCapital.
HealthXCapital typically leads investment rounds in the startups they back, particularly in the early stages.
The firm is open to follow-on investments, especially for companies that demonstrate significant growth and alignment with their healthcare focus.
Specific details about the fund size are not publicly disclosed, but the firm is focused on early-stage investments in healthcare.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.